| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787533 | Journal of Thoracic Oncology | 2018 | 24 Pages |
Abstract
BRAF mutant NSCLC is associated with high level of PD-L1 expression, low/intermediate TMB and microsatellite-stable status. ICPi have favorable activity both in BRAF V600E and BRAF non-V600E mutant NSCLC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Elizabeth MD, Nir MD, PhD, Hovav MD, PhD, Mira MD, Amir MD, Abed MD, Mor MD, Shoshana MD, Noa MD, Damien MD, Moshe MD, Alona MD, Aaron M. MD, Natalie Maimon MD, Ofer MD, Teodor MD, Tzippy BSc, Laila C. PhD, Jair PhD,